TB Alliance

Established in 2000 to address an urgent health need, TB Alliance relentlessly pursues its mission of discovering and developing improved TB treatments that can bring hope, and health, to millions. Today, the organization manages the largest portfolio of new TB drug candidates ever assembled, and leads the global effort to transform TB therapy. Their mission is to discover and develop better, faster-acting, and affordable drugs to fight tuberculosis. From this global network, the TB Alliance leverages the most promising science to advance new TB drug regimens that are needed to fight this pandemic.

Headquarter Address

40 Wall Street
24th Floor
New York, NY 10005